BioLife Solutions to Attend and Present at Upcoming Investor Conferences

Cowen presentation is scheduled for Wednesday, March 9th from 12:50-1:30pm ET in Track 12

KeyBanc presentation will be a fireside chat on Wednesday, March 23rd - tentatively scheduled for 4:30pm ET.

BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, today announced Mike Rice, Chairman and CEO, Rod de Greef, President and COO, and Troy Wichterman, CFO, are scheduled to present at both the Cowen and KeyBanc Investor Conferences in March 2022.

COWEN 42nd Annual Health Care Conference (Virtual)Track 12Wednesday, March 9th12:50-1:20pm ET https://www.cowen.com/conferences-and-events/42nd-annual-health-care-conference/

KeyBanc Life Sciences & MedTech ForumFireside ChatWednesday, March 23rd4:30pm ET

About BioLife Solutions

BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor® and HypoThermosolÒ biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system,  high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools.  For more information, please visit www.biolifesolutions.com, www.scisafe.com, www.stirlingultracold.com, or www.sextonbio.com and follow BioLife on Twitter.

Media & Investor Relations

At the Company

Troy Wichterman Chief Financial Officer (425) 402-1400 twichterman@biolifesolutions.com

Investors

LHA Investor RelationsJody Cain(310) 691-7100jcain@lhai.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-attend-and-present-at-upcoming-investor-conferences-301492598.html

SOURCE BioLife Solutions, Inc.